Pancreatic Cancer: Radiologic Imaging

Gastroenterology Clinics of North America

Volumn 41, Issue 1, 2012, Pages 159-177

  Jeffrey, R Brooke ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Cancer; Fluorodeoxyglucose positron emission tomography (FDG PET); Imaging; Multidetector computed tomography (MDCT); Pancreas

Indexed keywords

CONTRAST MEDIUM; IODINATED CONTRAST MEDIUM; NONIONIC CONTRAST MEDIUM;

AUTOIMMUNE PANCREATITIS; CANCER INFILTRATION; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER METASTASIS; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS BIOPSY; PANCREAS CALCIFICATION; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PATIENT SELECTION; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STOMACH DISTENSION; SURVIVAL TIME;

ADENOCARCINOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM STAGING; PANCREATIC NEOPLASMS;

EID: 84857067063     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.12.012     Document Type: Review

References (52)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Raimondi S., Maisonneuve P., Lowenfels A.B. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 2009, 6:699-708.
3. Ghiorzo P., Gargiulo S., Nasti S., et al. Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy. J Clin Oncol 2007, 25:5336-5337.
4. Whelan A.J., Bartsch D., Goodfellow P.J. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995, 333:975-977.
5. Ferrone C.R., Levine D.A., Tang L.H., et al. BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. J Clin Oncol 2009, 27:433-438.
6. Crist D.W., Sitzmann J.V., Cameron J.L. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987, 206:358-365.
7. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000, 4:567-579.
8. Berger H.G., Rau G., Gansauge F., et al. Treatment of pancreatic cancer: challenge of the facts. World J Surg 2003, 27:10075-10084.
9. Howard T.J., Krug J.E., Yu J., et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006, 10:1338-1345.
10. Geer R.J., Brennan M.F. Prognostic indicators for survival after resection of adenocarcinoma of the pancreas. Am J Surg 1993, 165:68.
11. Kayahara M., Nagakawa T., Futagami F., et al. Lymphatic flow and neural plexus invasion associated with carcinoma of the body and tail of the pancreas. Cancer 1996, 78(12):2485-2491.
12. Yi S.Q., Miwa K., Ohta T., et al. Innervation of the pancreas from the perspective of perineural invasion of pancreatic caner. Pancreas 2003, 27(3):225-229.
13. Mitsunaga S., Hasebe T., Kinoshita T., et al. Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact. Am J Surg Pathol 2007, 31(11):1636-1644.
14. Allema J.H., Reinders M.E., van Gulik T.M., et al. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery 1995, 117(3):247-253.
15. Shami V.M., Mahajan A., Loch M.M., et al. Comparison between endoscopic ultrasound and magnetic resonance imaging for the staging of pancreatic cancer. Pancreas 2011, 40(4):567-570.
16. Kinney T. Evidence-based imaging of pancreatic malignancies. Surg Clin North Am 2010, 90(2):235-249.
17. Grassetto G., Rubello D. Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer. Am J Clin Oncol 2011, 34(2):111-114.
18. Vargas R., Nino-Murcia M., Trueblood W., et al. MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 2004, 182(2):419-425.
19. Nino-Murcia M., Jeffrey R.B., Beaulieu C.F., et al. Multidetector CT of the pancreas and bile duct system: value of curved planar reformations. AJR Am J Roentgenol 2001, 176(3):689-693.
20. Prokesch R.W., Chow L.C., Beaulieu C.F., et al. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 2002, 224(3):764-768.
21. Salles A., Nino-Murcia M., Jeffrey R.B. CT of pancreas: minimum intensity projections. Abdom Imaging 2008, 33(2):207-213.
22. Kaneko O.F., Lee D.M., Wong J., et al. Performance of multidetector computed tomographic angiography in determining surgical resectability of pancreatic head adenocarcinoma. J Comput Assist Tomogr 2010, 34(5):732-738.
23. Zamboni G.A., Kruskal J.B., Vollmer C.M., et al. Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation. Radiology 2007, 245(3):770-778.
24. Manak E., Merkel S., Klein P., et al. Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations. Abdom Imaging 2009, 34(1):75-80.
25. Schima W., Ba-Ssalamah A., Goetzinger P., et al. State-of-the-art magnetic resonance imaging of pancreatic cancer. Top Magn Reson Imaging 2007, 18:421-429.
26. Deshmukh S.D., Willmann J.K., Jeffrey R.B. Pathways of extrapancreatic perineural invasion by pancreatic adenocarcinoma: evaluation with 3D volume-rendered MDCT imaging. AJR Am J Roentgenol 2010, 194(3):668-674.
27. Pham D.T., Hura S.A., Willmann J.K., et al. Evaluation of periampullary pathology with CT volumetric oblique coronal reformations. AJR Am J Roentgenol 2009, 193(3):W202-W208.
28. Park H.S., Lee J.M., Choi H.K., et al. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 2009, 30(3):586-595.
29. Mehmet Erturk S., Ichikawa T., Sou H., et al. Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension. J Comput Assist Tomogr 2006, 30(4):583-590.
30. Hollett M.D., Jorgensen M.J., Jeffrey R.B. Quantitative evaluation of pancreatic enhancement during dual-phase helical CT. Radiology 1995, 195(2):359-361.
31. Kim J.H., Park S.H., Yu E.S., et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 2010, 257(1):87-96.
32. Yoon S.H., Lee J.M., Cho J.Y., et al. Small (< 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 2011, 259(2):442-452.
33. Goodman M., Willmann J.K., Jeffrey R.B. Incidentally discovered solid pancreatic masses: imaging and clinical observations. Abdom Imaging 2011, [Epub ahead of print].
34. Horton K.M., Fishman E.K. Multidetector CT angiography of pancreatic carcinoma. AJR Am J Roentgenol 2002, 178:827-831.
35. Brennan D.D.D., Zamboni G.A., Raptopoulos V.D., et al. Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT. Radiographics 2007, 27:1653-1666.
36. Yoshinaga S., Suzuki H., Oda I., et al. Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc 2011, 23(Suppl 1):29-33.
37. Yasuda I., Iwashita T., Doi S., et al. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc 2011, 23(Suppl 1):22-25.
38. Springett G.M., Hoffe S.E. Borderline resectable pancreatic cancer: on the edge of survival. Cancer Control 2008, 15(4):295-307.
39. Lal A., Christians K., Evans D.B. Management of borderline resectable pancreatic cancer. Surg Oncol Clin N Am 2010, 19(2):359-370.
40. Chun Y.S., Milestone B.N., Watson J.C., et al. Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol 2010, 17(11):2832-2838.
41. Callery M.P., Chang K.J., Fishman E.K., et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 2009, 16:1727-1733.
42. Sai M., Mori H., Kiyonaga M., et al. Peripancreatic lymphatic invasion by pancreatic carcinoma: evaluation with multi-detector row CT. Abdom Imaging 2010, 35(2):154-162.
43. Ishikawa O., Ohigashi H., Imaoka S., et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992, 215:231-236.
44. Lehmann K.J., Diehl S.J., Lachmann R., et al. Value of dual-phase-helical CT in the preoperative diagnosis of pancreatic cancer-a prospective study. Röfo 1998, 168:211-216.
45. Li H., Zeng M.S., Zhou K.R., et al. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr 2005, 29:170-175.
46. Tamm E.P., Loyer E.M., Faria S., et al. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 2006, 31:568-574.
47. Nakayama Y., Yamashita Y., Kadota M., et al. Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results. J Comput Assist Tomogr 2001, 25:337-342.
48. Klauss M., Mohr A., von Tengg-Kobligk H., et al. A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography. Pancreatology 2008, 8:204-210.
49. Lee H., Lee J.K., Kang S.S., et al. Is there any clinical or radiologic feature as a preoperative marker for differentiating mass-forming pancreatitis from early-stage pancreatic adenocarcinoma?. Hepatogastroenterology 2007, 54(79):2134-2140.
50. Lo R.S., Singh R.K., Austin A.S., et al. Autoimmune pancreatitis presenting as a pancreatic mass mimicking malignancy. Singapore Med J 2011, 52(4):e79-e81.
51. Makino I., Kitagawa H., Ohta T., et al. Nerve plexus invasion in pancreatic cancer: spread patterns on histopathologic and embryological analyses. Pancreas 2008, 37(4):358-365.
52. Ceyhan G.O., Schäfer K.H., Kerscher A.G., et al. Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann Surg 2010, 251(5):923-931.